Cargando…
Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic
BACKGROUND: Allergen immunotherapy (AIT) must be continued for 3 years, to achieve a long-term modifying effect. Adherence is a key to ensure effectiveness. The objective of this study was, first of all, to evaluate the adherence with subcutaneous immunotherapy (SCIT) and to identify the main causes...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
World Allergy Organization
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185179/ https://www.ncbi.nlm.nih.gov/pubmed/34122718 http://dx.doi.org/10.1016/j.waojou.2021.100558 |